Atrial Fibrillation

Catheter ablation of atrial fibrillation in heart failure reduces mortality and hospitalization: The CASTLE-AF trial

Compared with medical therapy alone, catheter ablation of atrial fibrillation in patients with heart failure reduced the risk for all-cause mortality and hospitalization.

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

By

Patients with persistent atrial fibrillation who received targeted therapy saw improvements in sinus rhythm as well as reductions in blood pressure, cholesterol, and weight.

A 45-Year-Old Man Presents to the ED With Shortness of Breath, Confusion

A 45-Year-Old Man Presents to the ED With Shortness of Breath, Confusion

By

A 45-year-old man presents to the emergency department with some mental confusion and near syncope.

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

By

Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.

A 35-Year-Old Pregnant Woman Presents With Progressive Dyspnea and Palpitations

A 35-Year-Old Pregnant Woman Presents With Progressive Dyspnea and Palpitations

By

A 35-year-old pregnant woman presents to the emergency department with progressive dyspnea and palpitations that have worsened during the last 3 weeks.

Stroke, Other CV Risks, Increased With Migraine

Stroke, Other CV Risks, Increased With Migraine

Migraine was associated with elevated risks of myocardial infarction, stroke (ischemic and hemorrhagic), venous thromboembolism, and atrial fibrillation or flutter.

Atrial Fibrillation With Heart Failure: Better Outcomes With Ablation

Atrial Fibrillation With Heart Failure: Better Outcomes With Ablation

Catheter ablation was associated with a significant reduction in a composite end point of death from any cause or hospitalization for worsening heart failure in patients with atrial fibrillation.

Clinical Case: Appropriate Cardiovascular Workup After Acute Hemiparesis

Clinical Case: Appropriate Cardiovascular Workup After Acute Hemiparesis

By

The next best diagnostic step in the workup of acute ischemic stroke in context of updated 2018 guidelines is discussed.

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

By

Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.

Bleeding, Thromboembolic Events With Apixaban Interruption During Afib Ablation

Bleeding, Thromboembolic Events With Apixaban Interruption During Afib Ablation

Uninterrupted and minimally interrupted apixaban are associated with low rates of thromboembolic events in patients undergoing catheter ablation for nonvalvular afib.

Electrocardiogram Use for Afib, CVD Prevention Reviewed by USPSTF

Electrocardiogram Use for Afib, CVD Prevention Reviewed by USPSTF

Current evidence is inadequate to assess benefits and harms of ECG screening for atrial fibrillation.

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

By

Cost-effective DOACs like apixaban prevent strokes better than warfarin in patients with atrial fibrillation.

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

By

In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.

Atrial Fibrillation-Related Hospital Deaths Vary by Geographic Area

Atrial Fibrillation-Related Hospital Deaths Vary by Geographic Area

In patients with atrial fibrillation, in-hospital mortality is higher in rural hospitals vs urban hospitals.

Bleeding Risk Scores Compared in Atrial Fibrillation

Bleeding Risk Scores Compared in Atrial Fibrillation

Four clinical bleeding risk scores are able to identify the atrial fibrillation patients who are at risk for major bleeding.

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

By

Patients who had short-run atrial tachyarrhythmia experienced significantly higher rates of stroke compared with patients who did not have short-run atrial tachyarrhythmia.

Effect of Cardiologist Care on New-Onset Atrial Fibrillation Outcomes

Effect of Cardiologist Care on New-Onset Atrial Fibrillation Outcomes

In patients with new-onset atrial fibrillation, cardiologist care is associated with lower rates of death.

Renal Function Outcomes in Atrial Fibrillation With Oral Anticoagulation Therapy

Renal Function Outcomes in Atrial Fibrillation With Oral Anticoagulation Therapy

By

Patients with atrial fibrillation who are treated with oral anticoagulants often experience renal function decline.

Warfarin Chemical Stability Not Affected by Repackaging Into Dose Administration Aids

Warfarin Chemical Stability Not Affected by Repackaging Into Dose Administration Aids

The chemical stability of warfarin sodium tablets is not affected by repackaging into dose administration aids.

Leukocyte Telomere Length as Potential Biomarker for Atrial Fibrillation

Leukocyte Telomere Length as Potential Biomarker for Atrial Fibrillation

By

No significant association was found between atrial fibrillation risk and leukocyte telomere length.

Atrial Fibrillation Detected on Apple Watch Heart Rhythm Device

Atrial Fibrillation Detected on Apple Watch Heart Rhythm Device

By

FDA has cleared the KardiaBand device to recordtheir EKG to detect normal heart rhythms and atrial fibrillation.

Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus Statement

Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus Statement

By

A new consensus statement provides updated guidelines for antithrombotic therapy in patients with atrial fibrillation associated with valvular heart disease.

ACC Expert Consensus: Management of Bleeding Associated With Oral Anticoagulants

ACC Expert Consensus: Management of Bleeding Associated With Oral Anticoagulants

By

The American College of Cardiology released an expert consensus decision pathway intended to guide clinicians in managing bleeding in patients treated with anticoagulation.

Atrial Fibrillation Ablation Lowers Risk for Recurrent Stroke

Atrial Fibrillation Ablation Lowers Risk for Recurrent Stroke

Ablation is associated with reduced risk of recurrent stroke in patients with atrial fibrillation.

Worsening Heart Palpitations With Hypertension and Obesity: A Case Study

Worsening Heart Palpitations With Hypertension and Obesity: A Case Study

By

A 46-year-old obese man with a history of hypertension and hyperlipidemia presents to the emergency department with worsening palpitations.

Subclinical Atrial Fibrillation Detection: Holter vs Insertable Cardiac Monitor

Subclinical Atrial Fibrillation Detection: Holter vs Insertable Cardiac Monitor

By

Continuous monitoring with an insertable cardiac monitor was found to be superior at detecting subclinical atrial fibrillation compared with a Holter monitor.

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

By

The 10 mg dose of rivaroxaban substantially lowered the risk for recurrent venous thromboembolism.

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

By

A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.

Bleeding Events in Atrial Fibrillation: Assessing Risk Prediction Models

Bleeding Events in Atrial Fibrillation: Assessing Risk Prediction Models

By

Risk prediction models to assess bleeding risk in patients with atrial fibrillation may be useful for optimizing treatment.

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

By

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

Sign Up for Free e-Newsletters